Evolva Holding SA (EVE) - Net Assets
Based on the latest financial reports, Evolva Holding SA (EVE) has net assets worth CHF6.24 Million CHF (≈ $7.88 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF7.08 Million ≈ $8.96 Million USD) and total liabilities (CHF849.50K ≈ $1.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Evolva Holding SA liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF6.24 Million |
| % of Total Assets | 88.01% |
| Annual Growth Rate | -14.55% |
| 5-Year Change | -95.45% |
| 10-Year Change | -96.76% |
| Growth Volatility | 64.0 |
Evolva Holding SA - Net Assets Trend (2005–2024)
This chart illustrates how Evolva Holding SA's net assets have evolved over time, based on quarterly financial data. Also explore EVE current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Evolva Holding SA (2005–2024)
The table below shows the annual net assets of Evolva Holding SA from 2005 to 2024. For live valuation and market cap data, see EVE company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CHF6.60 Million ≈ $8.34 Million |
+18.80% |
| 2023-12-31 | CHF5.55 Million ≈ $7.02 Million |
-94.77% |
| 2022-12-31 | CHF106.24 Million ≈ $134.31 Million |
-19.38% |
| 2021-12-31 | CHF131.77 Million ≈ $166.59 Million |
-9.18% |
| 2020-12-31 | CHF145.09 Million ≈ $183.44 Million |
-15.92% |
| 2019-12-31 | CHF172.56 Million ≈ $218.17 Million |
-11.12% |
| 2018-12-31 | CHF194.16 Million ≈ $245.47 Million |
-12.03% |
| 2017-12-31 | CHF220.72 Million ≈ $279.05 Million |
+27.54% |
| 2016-12-31 | CHF173.06 Million ≈ $218.79 Million |
-14.92% |
| 2015-12-31 | CHF203.42 Million ≈ $257.17 Million |
+16.24% |
| 2014-12-31 | CHF174.99 Million ≈ $221.24 Million |
+110.13% |
| 2013-12-31 | CHF83.28 Million ≈ $105.29 Million |
+35.99% |
| 2012-12-31 | CHF61.24 Million ≈ $77.42 Million |
-16.36% |
| 2011-12-31 | CHF73.22 Million ≈ $92.57 Million |
+38.23% |
| 2010-12-31 | CHF52.97 Million ≈ $66.97 Million |
-22.03% |
| 2009-12-31 | CHF67.93 Million ≈ $85.89 Million |
+210.74% |
| 2008-12-31 | CHF21.86 Million ≈ $27.64 Million |
-67.43% |
| 2007-12-31 | CHF67.12 Million ≈ $84.86 Million |
+2.51% |
| 2006-12-31 | CHF65.48 Million ≈ $82.78 Million |
-49.97% |
| 2005-12-31 | CHF130.88 Million ≈ $165.47 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Evolva Holding SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 36899722000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CHF7.23 Million | 109.62% |
| Other Comprehensive Income | CHF45.07 Million | 683.33% |
| Other Components | CHF429.50 Million | 6511.24% |
| Total Equity | CHF6.60 Million | 100.00% |
Evolva Holding SA Competitors by Market Cap
The table below lists competitors of Evolva Holding SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mountain Lake Acquisition Corp. Right
NASDAQ:MLACR
|
$7.08 Million |
|
Sentra Food Indonesia Tbk PT
JK:FOOD
|
$7.08 Million |
|
Tri-Mode System M Bhd
KLSE:0199
|
$7.09 Million |
|
SCC Holdings Bhd
KLSE:0158
|
$7.09 Million |
|
Synlogic Inc
NASDAQ:SYBX
|
$7.08 Million |
|
Vape Holdings Inc
NASDAQ:VAPE
|
$7.08 Million |
|
Lendway Inc.
NASDAQ:LDWY
|
$7.07 Million |
|
Atlas Cycles (Haryana) Limited
NSE:ATLASCYCLE
|
$7.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evolva Holding SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,552,600 to 6,596,300, a change of 1,043,700 (18.8%).
- Net income of 1,044,000 contributed positively to equity growth.
- Share repurchases of 163,100 reduced equity.
- Other comprehensive income increased equity by 45,074,399.
- Other factors decreased equity by 44,911,599.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF1.04 Million | +15.83% |
| Share Repurchases | CHF163.10K | -2.47% |
| Other Comprehensive Income | CHF45.07 Million | +683.33% |
| Other Changes | CHF-44.91 Million | -680.86% |
| Total Change | CHF- | 18.80% |
Book Value vs Market Value Analysis
This analysis compares Evolva Holding SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.07x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.00x to 1.07x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | CHF1774.36 | CHF0.98 | x |
| 2006-12-31 | CHF775.76 | CHF0.98 | x |
| 2007-12-31 | CHF699.51 | CHF0.98 | x |
| 2008-12-31 | CHF208.51 | CHF0.98 | x |
| 2009-12-31 | CHF199.03 | CHF0.98 | x |
| 2010-12-31 | CHF73.50 | CHF0.98 | x |
| 2011-12-31 | CHF89.47 | CHF0.98 | x |
| 2012-12-31 | CHF69.78 | CHF0.98 | x |
| 2013-12-31 | CHF70.03 | CHF0.98 | x |
| 2014-12-31 | CHF124.32 | CHF0.98 | x |
| 2015-12-31 | CHF119.65 | CHF0.98 | x |
| 2016-12-31 | CHF90.00 | CHF0.98 | x |
| 2017-12-31 | CHF114.47 | CHF0.98 | x |
| 2018-12-31 | CHF62.99 | CHF0.98 | x |
| 2019-12-31 | CHF56.00 | CHF0.98 | x |
| 2020-12-31 | CHF46.10 | CHF0.98 | x |
| 2021-12-31 | CHF37.44 | CHF0.98 | x |
| 2022-12-31 | CHF24.82 | CHF0.98 | x |
| 2023-12-31 | CHF1.03 | CHF0.98 | x |
| 2024-12-31 | CHF0.91 | CHF0.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evolva Holding SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.83%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.14x
- Recent ROE (15.83%) is above the historical average (-123.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -26.77% | 0.00% | 0.00x | 1.04x | CHF-48.13 Million |
| 2006 | -110.77% | -26513.74% | 0.00x | 1.28x | CHF-79.08 Million |
| 2007 | -88.08% | -35937.03% | 0.00x | 1.29x | CHF-65.83 Million |
| 2008 | -39.62% | -2040.98% | 0.01x | 2.03x | CHF-10.85 Million |
| 2009 | -14.22% | -50.77% | 0.20x | 1.37x | CHF-16.37 Million |
| 2010 | -44.88% | -125.07% | 0.25x | 1.45x | CHF-28.49 Million |
| 2011 | -30.89% | -202.64% | 0.10x | 1.47x | CHF-29.72 Million |
| 2012 | -26.13% | -228.19% | 0.08x | 1.48x | CHF-22.13 Million |
| 2013 | -19.49% | -180.70% | 0.08x | 1.30x | CHF-23.80 Million |
| 2014 | -12.33% | -230.02% | 0.04x | 1.23x | CHF-38.67 Million |
| 2015 | -15.82% | -339.28% | 0.04x | 1.15x | CHF-52.05 Million |
| 2016 | -21.02% | -411.19% | 0.04x | 1.16x | CHF-53.08 Million |
| 2017 | -17.66% | -569.26% | 0.03x | 1.09x | CHF-61.05 Million |
| 2018 | -15.05% | -327.03% | 0.04x | 1.10x | CHF-48.63 Million |
| 2019 | -12.54% | -186.61% | 0.06x | 1.11x | CHF-38.90 Million |
| 2020 | -20.59% | -396.10% | 0.05x | 1.15x | CHF-44.38 Million |
| 2021 | -31.32% | -417.76% | 0.06x | 1.19x | CHF-54.44 Million |
| 2022 | -40.82% | -279.08% | 0.12x | 1.23x | CHF-53.99 Million |
| 2023 | -1895.13% | -1114.95% | 0.96x | 1.77x | CHF-105.78 Million |
| 2024 | 15.83% | 0.00% | 0.00x | 1.14x | CHF384.37K |
Industry Comparison
This section compares Evolva Holding SA's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $153,398,342
- Average return on equity (ROE) among peers: -34.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evolva Holding SA (EVE) | CHF6.24 Million | -26.77% | 0.14x | $7.08 Million |
| Addex Therapeutics Ltd (ADXN) | $33.84 Million | -92.04% | 0.29x | $7.10 Million |
| BB Biotech AG (BION) | $1.91 Billion | 10.59% | 0.00x | $2.25 Billion |
| Basilea Pharmaceutica AG (BSLN) | $125.38 Million | -47.04% | 0.20x | $699.48 Million |
| Idorsia Ltd (IDIA) | $-1.21 Billion | 0.00% | 0.00x | $759.27 Million |
| Molecular Partners AG (MOLN) | $135.79 Million | -13.71% | 0.36x | $145.86 Million |
| Newron Pharmaceuticals SpA (NWRN) | $29.28 Million | -80.19% | 0.42x | $360.88 Million |
| Relief Therapeutics Holding AG (RLF) | $14.30 Million | -52.18% | 0.39x | $36.33 Million |
| Santhera Pharmaceuticals Holding AG (SANN) | $104.47 Million | -42.74% | 0.08x | $244.59 Million |
| Xlife Sciences AG (XLS) | $235.23 Million | 6.08% | 1.08x | $122.27 Million |
About Evolva Holding SA
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more